Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities, Prevention, Management, Cause & Risk
Executive Summary
Age-related macular degeneration (AMD) is a condition affecting older people, and involves the loss of the person\'s central field of vision. Several forms of AMD exist such as early AMD, late AMD, dry AMD, Wet AMD etc. Globally, the disease ranks third as a cause of blindness after cataract and glaucoma. The main factor is ageing and other risk factors may include the use of tobacco, genetic tendencies, the degree of pigmentation (with light colored eyes being at higher risk), arterial hypertension, the ultraviolet rays, and consumption of a non-balanced diet. As for the cure of the disease, there is at present no definitive treatment. Palliative treatments which are able to retard the progress of the disease include the use of intravitreous drugs or injections, lasers, dynamic phototherapy and sometimes surgery.
Globally the prevalence of AMD disease is highest in the U.S followed by the U.K and Australia. The world’s elderly population is the fastest growing age group; this is the main reason for the rising prevalence of AMD. Rising smoking habit, and unhealthy diet are the other reasons which will increase the count of AMD affected people in the near future. New types of drugs such as Eylea have come up which is indicated for the treatment of patients with neovascular (wet) age related macular degeneration and expected to substitute Lucentis and Avastin drugs in the coming years.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=186845
Scope of the Report
The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration market with detailed analysis of various countries like the United States, U.K, Australia. It also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall AMD market has also been forecasted for the period 2013-2018, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Norvatis, Regeneron, Roche and Bayer are profiled.
Regional Coverage
U.S
U.K
Australia
Read All Ophthalmic Devices Market Research Reports @ http://www.researchmoz.us/ophthalmic-devices-market-reports-46.html
Table of Content
1. Executive Summary
2. Age-Related Macular Degeneration (AMD): An Introduction
2.1 Sign and Symptoms of AMD
2.2 Causes and Risk Factors of AMD
2.3 Diagnosis of AMD
2.4 Treatment of AMD
2.4.1 Treatment of Wet AMD
2.4.2 Treatment of Dry AMD
3. Global Age-Related Macular Degeneration Market: Analysis and Forecast
3.1 Global AMD Market: Sizing and Growth
3.1.1 Global AMD Market Size by Value: Actual and Forecast
3.1.2 Global AMD Market Size by Volume: Actual and Forecast
3.2 Global Market Share of AMD
3.2.1 AMD Market Share by Type
3.2.2 AMD Market Share by Country
3.2.3 Common Causes of Blindness- Percentage Share
3.2.4 Common Causes of Visual Impairment- Percentage Share
3.3 Worldwide Prevalence of AMD
3.3.1Prevalence of AMD by Stages
3.3.2 Prevalence of AMD by Type
3.3.3 Prevalence of AMD by Visual Impairment
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG